Back to search

Article

A Stromal-Immune Gene Signature for Precision Prognosis and Therapeutic Guidance in Gastric Cancer

2026-02-16

Abstract excerpt

<title>Abstract</title> <p>The tumor microenvironment (TME), especially the extracellular matrix (ECM) and immune milieu, drives gastric cancer (GC) progression and therapy resistance. However, prognostic biomarkers integrating these two dimensions remain lacking, limiting precise risk stratification and personalized treatment. We analyzed bulk transcriptomic data (TCGA-STAD, GSE15459, GSE62254), single-cell RNA-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fbade24e-25b8-51f9-a816-3a8ded7ddaa2
DOI
10.21203/rs.3.rs-8596508/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Stromal-Immune Gene Signature for Precision Prognosis and Therapeutic Guidance in Gastric CancerDOI 10.21203/rs.3.rs-8596508/v1
Combined scRNA-seq and bulk transcriptome analysis establishes a stromal signature for predicting prognosis and therapeutic sensitivity in gastric cancerSemantic proximity
Gastric Cancer Tumor Immune Microenvironment Landscape: Clinical Implications for Patient Outcome and Response to PD-1 Immune Checkpoint BlockadeSemantic proximity
Single-cell RNA sequencing and large-scale bulk combination with machine learning reveal gastric cancer-related macrophage heterogeneitySemantic proximity
Development of a Novel Anoikis-Related Prognostic Signature and Validation of CD36 as a Potential Target for Reversing 5-FU Resistance in Gastric CancerSemantic proximity
Integrin-based prognostic model predicts survival, immunotherapy response, and drug sensitivity in gastric cancerSemantic proximity
Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencingSemantic proximity
Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancerSemantic proximity
Construction of an immune-related risk score signature for gastric cancer based on multi-omics dataSemantic proximity
Representing ECM composition and EMT pathways in gastric cancer using a new metastatic gene signatureSemantic proximity
Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironmentSemantic proximity
Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures.Semantic proximity
Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapiesSemantic proximity
Select a neighboring publication to make it the new centre.